Literature DB >> 23019048

Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer.

Evropi Theodoratou1, Zahra Montazeri, Steven Hawken, Genevieve CdL Allum, Jacintha Gong, Valerie Tait, Iva Kirac, Mahmood Tazari, Susan M Farrington, Alex Demarsh, Lina Zgaga, Denise Landry, Helen E Benson, Stephanie H Read, Igor Rudan, Albert Tenesa, Malcolm G Dunlop, Harry Campbell, Julian Little.   

Abstract

BACKGROUND: Colorectal cancer is a major global public health problem, with approximately 950,000 patients newly diagnosed each year. We report the first comprehensive field synopsis and creation of a parallel publicly available and regularly updated database (CRCgene) that catalogs all genetic association studies on colorectal cancer (http://www.chs.med.ed.ac.uk/CRCgene/).
METHODS: We performed two independent systematic reviews, reviewing 10 145 titles, then collated and extracted data from 635 publications reporting on 445 polymorphisms in 110 different genes. We carried out meta-analyses to derive summary effect estimates for 92 polymorphisms in 64 different genes. For assessing the credibility of associations, we applied the Venice criteria and the Bayesian False Discovery Probability (BFDP) test.
RESULTS: We consider 16 independent variants at 13 loci (MUTYH, MTHFR, SMAD7, and common variants tagging the loci 8q24, 8q23.3, 11q23.1, 14q22.2, 1q41, 20p12.3, 20q13.33, 3q26.2, 16q22.1, and 19q13.1) to have the most highly credible associations with colorectal cancer, with all variants except those in MUTYH and 19q13.1 reaching genome-wide statistical significance in at least one meta-analysis model. We identified less-credible (higher heterogeneity, lower statistical power, BFDP >0.2) associations with 23 more variants at 22 loci. The meta-analyses of a further 20 variants for which associations have previously been reported found no evidence to support these as true associations.
CONCLUSION: The CRCgene database provides the context for genetic association data to be interpreted appropriately and helps inform future research direction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019048     DOI: 10.1093/jnci/djs369

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  53 in total

1.  KRAS polymorphisms are associated with survival of CRC in Chinese population.

Authors:  Qiong Dai; Hui Lian Wei; Juan Huang; Tie Jun Zhou; Li Chai; Zhi-Hui Yang
Journal:  Tumour Biol       Date:  2015-10-29

2.  COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.

Authors:  Karen W Makar; Elizabeth M Poole; Alexa J Resler; Brenna Seufert; Karen Curtin; Sarah E Kleinstein; David Duggan; Richard J Kulmacz; Li Hsu; John Whitton; Christopher S Carlson; Christine F Rimorin; Bette J Caan; John A Baron; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2013-12       Impact factor: 2.506

3.  A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Authors:  Christine Q Chang; Ajay Yesupriya; Jessica L Rowell; Camilla B Pimentel; Melinda Clyne; Marta Gwinn; Muin J Khoury; Anja Wulf; Sheri D Schully
Journal:  Eur J Hum Genet       Date:  2013-07-24       Impact factor: 4.246

4.  Association of MTHFR C677T polymorphisms and colorectal cancer risk in Asians: evidence of 12,255 subjects.

Authors:  X-P Guo; Y Wang; H Zhao; S-D Song; J Zhou; Y Han
Journal:  Clin Transl Oncol       Date:  2013-11-06       Impact factor: 3.405

5.  APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Authors:  Shi-Heng Zhang; Lin-Ang Wang; Zheng Li; Yu Peng; Yan-Ping Cun; Nan Dai; Yi Cheng; He Xiao; Yan-Li Xiong; Dong Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  Genetic architecture of colorectal cancer.

Authors:  Ulrike Peters; Stephanie Bien; Niha Zubair
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

7.  Innate immunity gene polymorphisms and the risk of colorectal neoplasia.

Authors:  Cindy M Chang; Victoria M Chia; Marc J Gunter; Krista A Zanetti; Bríd M Ryan; Julie E Goodman; Curtis C Harris; Joel Weissfeld; Wen-Yi Huang; Stephen Chanock; Meredith Yeager; Richard B Hayes; Sonja I Berndt
Journal:  Carcinogenesis       Date:  2013-06-26       Impact factor: 4.944

Review 8.  Familial colorectal cancer: a review.

Authors:  Franco Armelao; Giovanni de Pretis
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies.

Authors:  Ashwin N Ananthakrishnan; Mengmeng Du; Sonja I Berndt; Hermann Brenner; Bette J Caan; Graham Casey; Jenny Chang-Claude; David Duggan; Charles S Fuchs; Steven Gallinger; Edward L Giovannucci; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; John L Hopper; Lifang Hou; Li Hsu; Mark A Jenkins; Peter Kraft; Jing Ma; Hongmei Nan; Polly A Newcomb; Shuji Ogino; John D Potter; Daniela Seminara; Martha L Slattery; Mark Thornquist; Emily White; Kana Wu; Ulrike Peters; Andrew T Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-23       Impact factor: 4.254

10.  Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk.

Authors:  Hansong Wang; Darin Taverna; Daniel O Stram; Barbara K Fortini; Iona Cheng; Lynne R Wilkens; Terrilea Burnett; Karen W Makar; Noralane M Lindor; John L Hopper; Steve Gallinger; John A Baron; Robert Haile; Laurence N Kolonel; Brian E Henderson; Polly A Newcomb; Graham Casey; David Duggan; Cornelia M Ulrich; Loïc Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-17       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.